Background-Recent studies from Australia, New Zealand, and Sweden have reported declines in abdominal aortic aneurysm (AAA) incidence, prevalence, and mortality. This finding may have important implications for screening programs. This study determined trends in AAA incidence and mortality in England and Wales. Methods and Results-Cause-specific mortality data for England and Wales were obtained from UK Office for National Statistics, and hospital admissions and procedures data for England were obtained from Hospital Episode Statistics from 2001 to 2009. Poisson regression models were constructed to estimate the relative change over time. Age-standardized rates for AAA mortality in England and Wales fell significantly by 35.7% from 2001 to 2009, which was largely due to a 35.3% drop in age-standardized ruptured AAA deaths. During the same period, ruptured AAA admissions and emergency AAA repairs in England declined by 29.3% and 35.5%, respectively. In contrast, nonruptured AAA admissions remained static, and nonemergency AAA repairs increased by 17.2%. The average ages for hospital admissions for nonruptured AAAs and ruptured AAAs increased by 0.19 years of age per annum (PϽ0.001) and 0.09 years of age per annum (PϽ0.001), respectively. Nonruptured AAA admissions increased by 21.4% in age band 75 years or more but declined by 11.7% in ages Ͻ75 years. Conclusions-AAA mortality, ruptured AAA admission, and emergency AAA repair have declined in England and Wales.
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However, contemporary data from Western populations have suggested that this trend of rising AAA has not continued, and may in fact be reversing. Norman et al 8 reported a declining rate of hospitalization for both ruptured and nonruptured AAA with a 38% decline in AAA mortality in men from 1999 to 2006 in Australia. Similarly, Sandiford et al 9 reported a 53% reduction in AAA mortality in men from 1991 to 2007 in New Zealand, and a reduced rate of age-standardized hospitalization rate for AAAs. Both authors cited decreasing prevalence of smoking in their countries as the most likely explanation for the falling incidence of AAAs.
The UK Multicenter Aneurysm Screening Study 10 demonstrated that screening for AAA in men aged 65 to 74 years achieved substantial reduction in aneurysm-related mortality. However, this study was conducted between 1997 and 1999, when AAA incidence was still on the rise. Any decline in AAA incidence would be translated into a lower prevalence and effectiveness of current screening strategies. Preliminary results from the ongoing screening program in the United Kingdom 11 have indeed revealed a lower AAA prevalence. Svensjo et al 12 described a lowest reported AAA prevalence of 1.7% from their ultrasound-based AAA screening program for 65-year-old men in central Sweden and suggested that the cost-effectiveness of current screening strategies may need to be reevaluated on the basis of modern epidemiological data. If the recent trends continue, Lederle 13 advocated that programs that target high-risk populations such as older men who have smoked, in line with US Preventive Services Task Force recommendation, 1 are more likely to remain effective.
Contemporary epidemiology of AAA in England and Wales has not been subjected to recent examination. In view of the changing epidemiology of AAAs in other Western populations and its important implications for screening strategies, this study examined the trends in AAA mortality and incidence in England and Wales.
Methods
The International Classification of Diseases, 10th Revision (ICD-10) was used. The incidence of patients with AAA in England for the financial years 2000 to 2009 was estimated by the use of hospital admission counts that had primary diagnosis ICD-10 codes of I71.3, I71.4, I71.5, I71.6, I71.8, and I71.9 from the Hospital Episodes Statistics (HES) data. The primary diagnosis is the main condition treated or investigated during the episode of care. The ICD-10 codes I71.3, I71.4, I71.5, I71.6, I71.8, and I71.9 were abdominal and thoracoabdominal aortic aneurysms, ruptured or otherwise, and aortic aneurysms of unspecified site (ruptured or otherwise), as well. We opted to include thoracoabdominal and unspecified site aortic aneurysms in our analyses in line with the New Zealand study 9 ; this was slightly different from the Australian study, 8 which only included ICD-10 codes 171.3 and 171.4 for ruptured and nonruptured AAAs, respectively. This was to ensure that all lesions involving abdominal aneurysms were captured in the analyses.
AAA repair workload in England for the financial years 2000 to 2009 was estimated by the use of hospital main procedure and interventions data from HES. The main procedure and intervention need not be the first (eg, where major surgery is preceded by a biopsy), but is the one that is the most resource intensive. Procedures and interventions are recorded by the use of Office of Population, Censuses and Surveys Classification of Surgical Operations and Procedures (4th revision) (OPCS-4) according to the definitions used by the Vascular Society of Great Britain and Ireland to identify AAA operations for the National AAA Quality Improvement Programme. 14 15 was used for the coding of cause of death. All deaths with ICD-10 codes I71.3, I71.4, I71.5, I71.6, I71.8, and I71.9 were included, and these codes were assigned with the use of Medical Mortality Data Software, which is an automated cause-coding system software developed by the US National Center for Health Statistics. The purpose of using computer algorithms in an automated cause-coding software is to improve international and temporal comparability of mortality statistics. Specific text terms from death certificates are converted to ICD codes, and then selection and modification rules are assigned to apply the underlying cause of death. The exception to automated cause coding is coding of deaths certified after inquest. This coding is done manually by experienced coders, because the software cannot readily cope with the freeformat text used by coroners when describing the circumstances of death.
The processes of inputting mortality data into ONS death registrations are summarized in online-only Data Supplement Appendix I. The attending physician or the coroner (in the event of a postmortem) will certify the cause of death in the Medical Certificate of Cause of Death. This will be registered at the local registration office, and, once the death is registered satisfactorily following a series of checks, the local registrar then drafts the registration and sends a copy on a weekly basis to the ONS. ONS mortality data will therefore include deaths due to ruptured AAA outside the hospital, because these deaths will be certified in the deceased's death certificate as such by the community attending physician or by the coroner, before the usual processes through the local registration offices to the ONS.
Validity of Data
HES data are generated from the hospital records that flow from the providers of hospital care (the National Health Service hospital trusts) to the commissioners of care. There are Ͼ12 million records of admitted patient care each year. Similarly, vast quantities of mortality data are entered into ONS death registration each year. Both HES and ONS data are therefore subjected to a number of complex internal validation processes involving a wide range of people, organizations, and computer systems before becoming usable for analysis. Internal validation processes are present to ensure high quality of data for both HES and ONS, and these processes are summarized in online-only Data Supplement Appendices I and II.
An external validity study for AAA data reported by HES has been recently published. 16 This multicenter audit on HES AAA data quality assessed the completeness and accuracy of recordings of data in HES in comparison with gold standard data sets from hospital trusts on all elective AAA repairs in England. This study showed that recording within the HES database was 86.0% accurate in comparison with gold standard data sets from individual hospitals. In addition, this study reported a 99.8% accuracy of survival status in HES in comparison with that of the ONS.
With regard to external validity of ONS mortality data, the United Kingdom was recognized to provide high-quality data on the cause of deaths to World Health Organization in a large review of civil registration systems across the world. 17 Among the member states of the World Health Organization, the United Kingdom was among the 31 (13%) countries that provided high-quality data, with data completeness of 90% to 100%. Completeness of statistics on cause of death was defined as the ratio of number of deaths for which cause of death is registered to the civil registration system to the estimated total number of deaths in the population; the latter includes all deaths registered to the civil registration system (whether cause of death is mentioned or not) and those not registered to the civil registration system, as well.
Statistics
Age-standardized rates were calculated by the use of the World Health Organization World Standard Population. 18 The relative change in mortality from AAA and the incidence of hospital admissions for AAAs and their association with age, sex, and calendar period were estimated with the use of Poisson regression models. The relative change in age at presentation for nonruptured and ruptured AAA hospital admission was estimated by the use of linear regression. All statistical analysis was performed by using SPSS for Windows version 18 (SPSS, Chicago, IL).
Results

AAA Mortality in England and Wales
There has been a striking decline of 5.08% per annum (PϽ0.001) in age-standardized AAA mortality in England and Wales. Both age-standardized ruptured and nonruptured AAA mortalities have fallen significantly by 5.03% per annum (PϽ0.001) and 5.56% per annum (PϽ0.001), respectively ( Figure 1 ). Ruptured AAAs (84.6%) was a major contributor of overall AAA mortality, and the sharp decline in overall AAA mortality was largely due to a 54.6% drop in age-standardized ruptured AAA deaths since 2001.
AAA Hospital Admissions and Case Load in England
Age-standardized hospital admissions for ruptured AAAs in England have decreased significantly by a mean 3.62% per annum (PϽ0.001). Age-standardized emergency AAA repairs have similarly decreased significantly by a mean 4.52% per annum (PϽ0.001) ( Figure 2A ). In contrast, age-standardized hospital admissions for nonruptured AAAs have remained constant (mean change of Ϫ0.17% per annum, Pϭ0.58) and age-standardized nonemergency repairs for AAAs have increased significantly by a mean of 1.45% per annum (PϽ0.001) ( Figure 2B ).
Age Stratification
Both ruptured and nonruptured AAA mortalities declined in all age bands. Ruptured AAA mortality declined by 7.25% per annum (PϽ0.001) and 3.73% per annum (PϽ0.001) in those Ͻ75 years old and those aged Ն75 years of age, respectively. Nonruptured AAA mortality fell by 7.58% per annum (PϽ0.001) and 4.43% per annum (PϽ0.001) in those Ͻ75 years of age and those aged Ն75 years, respectively ( Figure 3A) .
For ruptured AAA admissions, downward trends were seen for both those Ͻ75 years of age (decrease of 4.83% per annum, PϽ0.001) and in those Ն75 years of age (decrease of 2.34% per annum, PϽ0.001) ( Figure 4A ). There was a similar downward trend in emergency AAA repairs for both those Ͻ75 years old (decrease of 5.07% per annum, PϽ0.001) and in those aged Ն75 years of age (decrease of 3.97% per annum, PϽ0.001). When stratified by age bands, a divergence in age-standardized hospital admissions for nonruptured AAAs was seen. In those Ͻ75 years of age, this declined by 1.33% per annum (PϽ0.001). However, in those aged Ն75 years of age, there was an increase of 1.89% per annum (PϽ0.001) in age-standardized hospital admissions for nonruptured AAAs ( Figure 4B ). When age-specific rates were analyzed, nonemergency AAA repairs in those Ͻ75 years of age increased by 0.17% per annum (PϽ0.001), with an even larger increase of 4.33% per annum (PϽ0.001) in those aged Ն75 years of age.
Deaths outside hospitals were counted in the mortality data from ONS. This explains why there were more ruptured AAA deaths than ruptured AAA admissions, because there were a significant proportion of patients who died of ruptured AAA in the community without being admitted to the hospital. Conversely, all deaths from nonruptured AAAs resulted from nonruptured AAA repair in hospital. Therefore, the admissions for nonruptured AAAs must always exceed that of deaths from nonruptured AAAs, which is reflected by Figures  3A and 4B .
The average ages for hospital admissions for nonruptured AAAs and ruptured AAAs have increased by 0.19 years of age per annum (PϽ0.001) and 0.09 years of age per annum (PϽ0.001), respectively ( Figure 5 ).
Sex
Age-standardized AAA mortality for both men and women declined by 5.90% per annum (PϽ0.001) and 4.10% per annum (PϽ0.001), respectively ( Figure 3B ).
Significant declines were seen for ruptured AAA admissions for both men (decrease of 2.88% per annum, PϽ0.001) and women (decrease of 2.50% per annum, PϽ0.001). There was a similar downward trend in emergency AAA repairs for both men (decrease of 3.68% per annum, PϽ0.001) and women (decrease of 4.53% per annum, PϽ0.001) ( Figure 6A) .
In contrast, nonruptured AAA admission in men increased by 0.99% per annum (PϽ0.001). For women, nonruptured AAA admission declined by 0.25% per annum (Pϭ0.023). Nonemergency AAA repairs in men have increased by 2.69% per annum (PϽ0.001), and, similarly for women, there has been a rise of 1.66% per annum (PϽ0.001) ( Figure 6B ). 
Discussion
This study has demonstrated declines in AAA mortality, ruptured AAA admission, and emergency AAA repair across all age bands, and in both men and women, in England and Wales. These data are similar to the Australian 8 and New Zealand 9 data. However, unlike these previous studies, the rate of nonruptured AAA admission has remained steady, with an increasing rate in older population offsetting a decreasing rate in younger population, and the rate of nonemergency AAA repair has increased in both age bands. The question prompted by the present study is whether there has also been a true fall in overall incidence of AAA disease in England, in line with the previous studies from Australia and New Zealand. Sandiford et al 9 described a decline in AAA mortality, AAA hospital admissions, and AAA hospital death rates in New Zealand, but they did not separate ruptured from nonruptured AAAs. Norman et al 8 reported that there have been significant falls in the rates of hospital episodes and mortality for both nonruptured and ruptured AAAs in men and women since 1999 and suggested that the incidence of AAAs may be falling in Australia. Svensjo et al 12 reported that, in their AAA screening program for 65-year-old men in central Sweden, the prevalence of AAAs was only 1.7%, which was the "the lowest reported in a predominantly white population to this date," and hypothesized that this was caused by an overall decrease of the disease in the population. The current low prevalence of AAAs in the UK screening program 11 would also support the notion of a true fall in incidence of AAAs.
A decline in overall AAA incidence could explain the reduced incidence of ruptured AAAs reported in this study. However, the rate of nonruptured AAA admissions in England has remained unchanged in the past 10 years. One might expect this to decline in parallel with ruptured AAAs if there was a genuine decline in AAA incidence, but this may not necessarily be the case. The underlying causes of the observed changing epidemiology of AAAs are complex, and there are factors that may mask a decline in incidence of nonruptured aneurysms. First, nonruptured AAA admissions and nonemergency AAA repair may have been maintained by evolving clinical practice. Endovascular Aneurysm Repair 1 (EVAR 1) trial 19 demonstrated that EVAR had significant early survival advantages over open repair, and it is likely that clinical practice has subsequently changed toward the use of minimally invasive endovascular techniques in high-risk patients who would otherwise have been precluded from AAA repair. In the United Kingdom, the rate of endovascular repair for intact aneurysms has increased significantly from 20.2% in 2005 to 58.9% in 2009. 20 Furthermore, data from the present study (Figures 2, 4B , and 6B) demonstrated that the increases in overall, older age group and male nonemergency AAA repairs coincided with the publication of the EVAR 1 trial in 2004. Second, if medical management such as increased use of statin therapy 21 and decline in smoking 22 have successfully reduced the risk of AAA rupture, patients who would otherwise have presented with ruptured aneurysms may now present with intact aneurysms, and this effect may also obscure a fall in incidence of nonruptured AAAs. Third, an increased availability of imaging techniques may contribute toward an increased diagnosis of incidental nonruptured AAA in older men. Taking all these factors into account, it is likely that the trends in England and Wales are trailing behind those of Australia and New Zealand, and, after this plateau stage, it is anticipated that there will be a decline in overall nonruptured AAA admissions and nonemergency AAA repairs in the coming years.
Another consideration in terms of the complexities underlying the changing epidemiology of AAAs is the possibility of less intervention for small AAAs in response to the publications of the small AAA trials in 2002. 23, 24 This could explain some of the fall in admissions for nonruptured AAAs in the Ͻ75 years of age group. However, this cannot wholly explain the trend, because the falling rates in this age group were already seen before the publication of these studies. Second, the older age group has resisted the falling trend; therefore, changing clinical practice of less intervention was unlikely to have played a significant role.
Smoking is the single most important risk factor for AAA. 25 Declines in smoking rates have been identified as the most likely cause of the declining incidence of AAAs in previous studies. 8, 9, 12 The adult prevalence of smoking in Australia declined from 35% in 1980 to 23% in 2001, 26 and Statistics Sweden reported that daily smoking among 65year-old men in Sweden decreased from 32% in 1980 to 11% in 2007. 12 In England, the historical rise in the rate of AAA mortality from the 1950s to 1980s has been attributed to a cohort effect of tobacco addiction in the 20th century. 27 The highest recorded level of smoking among men in England was 82% in 1948, of which 65% smoked manufactured cigarettes. Smoking prevalence among women in 1948 was 41% and remained fairly constant until the early 1970s, peaking at 45% in the mid-1960s. 28 Overall prevalence among adults then fell steadily between the mid-1970s and early 1980s.
It is possible that faster rates of decline in smoking in Australia may explain why Australian data have shown a clear decline in rates of hospital admissions for nonruptured aneurysms, whereas data from England have not. After 1982, the rate of decline in smoking slowed in England, with prevalence falling to Ϸ1 percentage point every 2 years until the early 1990s when it leveled out. Since 2000, overall adult smoking rates have only been declining by Ϸ0.4% per annum, 29 and, between 2007 and 2008, overall smoking prevalence among adults remained the same at 21%. 30 For those Ͼ60 years of age, the rate of smoking in England was 16% in 1998 30 in comparison with only 10% in Australia in 2001. 26 The overall mortality from AAA in England and Wales has declined sharply since 2001. Aneurysm rupture was a major contributor of AAA mortality, and the sharp fall in overall AAA mortality was principally due to decreasing mortality from ruptured AAA, for which there are 2 explanations. First, the incidence of ruptured AAA has declined, as evident from declines in hospital admissions for ruptured AAA and falls in emergency AAA caseloads in the present study. This declining incidence of ruptured AAAs was probably due to a combination of reduced overall incidence of AAAs and of better control of risk factors for AAA rupture. Improvement in uptake of statin therapy, 21 decline in smoking, and better control of blood pressure 22 are all potential factors that can reduce the incidence of AAA rupture. Second, there is recent evidence for improved perioperative outcome for ruptured aneurysm repair. The recently published Vascunet registry AAA data 20 (from 9 participating countries) reported that in-hospital mortality has decreased significantly from 42.5% in 2005 to 28.5% in 2009 for ruptured aneurysm repairs in the United Kingdom.
An appealing explanation is that there may be evidence that elective (prophylactic) repair of AAAs is achieving its aim. The combination of increased elective workload, better case selection, and better elective perioperative outcome may have contributed to the decline in incidence of ruptured AAAs and overall AAA mortality. As previously alluded, elective AAA workload has increased and was temporally related to the publication of the EVAR 1 trial in 2004. The UK Small Aneurysm Trial (SAT) and the Aneurysm Detection and Management (ADAM) trial have improved case selection to AAAs Ͼ5.5 cm. The Vascunet registry data 20 reported that in-hospital mortality has decreased from 5.5% in 2005% to 3% in 2009 for elective aneurysm repairs. It is important, however, to note that the declines in incidence of ruptured AAAs and AAA mortality were already present before the publication of the UK SAT and ADAM trials in 2002 or the EVAR 1 trial in 2004. Therefore, increased elective workload and better case selection cannot wholly explain the trend.
Regardless of whether there has been a true accompanying decline in overall incidence of AAAs, mortality has unquestionably declined sharply in the past 10 years, and any continuing trend of declining AAA mortality may challenge the cost-effectiveness of AAA-screening programs. It is therefore crucial that these recent trends be monitored and screening strategies reevaluated accordingly on the basis of these trends to maintain their effectiveness. On the basis of the present change in epidemiology, data are emerging from age band and sex analyses that may be imperative to optimization of strategies for screening.
When stratified into age bands, the most striking finding was an increase in nonruptured AAA hospital admissions and nonemergency AAA repairs in those aged Ն75 years. In those Ͻ75 years, the opposite was true, in that hospital admission rates declined for nonruptured AAAs. The average age for AAA hospital admissions also increased significantly from 2000 to 2009. The most likely explanation is that declining smoking rates shifted the age of AAA presentation to the older population. AAA is a multifaceted disease with multiple risk factors including a strong association with genetic factors. 31, 32 Although smoking is a key risk factor for AAA, it is possible that the decline in smoking may serve to delay the onset of the disease in genetically predisposed individuals rather than reduce its incidence altogether. This would explain the decreasing prevalence of AAAs among men aged 65 years screened for AAAs. As aortic aneurysms primarily affect the elderly population, the increase in life expectancy over time in England may also result in a longer lifespan to develop the disease and therefore increase the age at which AAAs become clinically significant. Over the past 3 decades, the average life expectancy of a man aged 60 years in England has increased significantly, from 16.4 years in 1981 to 21.7 years in 2008. 33 Because of the increasing incidence of nonruptured AAAs in those aged Ն75 years, it might be necessary to rescreen the entire population at a higher age. However, the costeffectiveness of such a strategy must be balanced against the reduced gain in life years in the older cohort. If incidence of nonruptured AAAs in population Ͻ75 years of age continued its downward trend, it is possible that the prevalence of AAAs in men aged 65 years will fall below the threshold needed to make screening at this age cost-effective.
It is difficult to explain why male admissions for nonruptured AAAs have increased, whereas female admissions have fallen. Regardless of causation, this again has important implications for AAA-screening program and with the current trend, limiting AAA screening to men only remains appropriate. With regard to smoking data in England, limiting AAA screening to male smokers (as suggested by Lederle 13 and as per previous US Preventive Service Task Force recommendation) may become necessary, if reduced rate of smoking continues to cause further reductions in the incidence of AAAs. In this respect, a cautious approach is necessary, because current evidence suggests that rates of decline in smoking are slowing 30 and may eventually level out. Furthermore, the reduced life expectancy among smokers will reduce any gains from limiting screening to male smokers only.
There are a number of limitations to this study. First, fluctuations in the HES data collection from year to year can happen for a number of reasons, such as organizational changes, reviews of best practice within the medical community, the implementation of new coding systems, and data quality issues that are often year specific. Second, HES records describe episodes (periods) of continuous admitted patient care under the same consultant. In cases where responsibility for a patient's care is transferred to a second, or subsequent, consultant there will be 2 or more HES records relating to the patient's stay (spell) in hospital. The HES data also fail to distinguish between possible multiple admissions for the same patient with the same principal diagnosis within any 1 year. Third, autopsy rates in the United Kingdom have declined from 42.7% in 1979 to 15.3% in 2001. 34 Although there have not been any reports on recent trends of autopsy rates in the United Kingdom, it is likely that autopsy rates have continued to fall, and failure to pick up sudden deaths caused by ruptured aneurysms may exaggerate the decline of the disease. Finally, EVAR procedures were given specific codes only after 2006, and it is likely that EVAR procedures may not have been completely captured on the HES database before 2006. As a result, this study may underestimate the decline in AAA repairs between 2000 and 2009.
Conclusions
This is the first study to provide direct evidence for a shift of AAA presentation to the older population. Taken together with declining AAA mortality, it may be appropriate to reassess present screening strategies, and this may include consideration for increasing the age at which to screen men for AAAs. Further trends for smoking in England need to be ascertained before selectively screening male smokers only. 
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CLINICAL PERSPECTIVE
Policies for abdominal aortic aneurysm (AAA) screening were principally influenced by historical data of rises in both mortality and incidence of AAAs. However, recent data from Western populations including Australia, New Zealand, Sweden, and the United States have suggested that this trend of rising AAA has not continued and may in fact be reversing. Similarly, this present study reported declines in AAA mortality, ruptured AAA admission, and emergency AAA repair in England and Wales. One may consider the emergence of these data to be ill-timed, because many countries are now priming to roll out AAA-screening programs, including plans to fully implement the screening program by 2013 in England. A decline in smoking is likely to have contributed to the reversal of the AAA epidemic. This study also reported a delayed presentation of nonruptured AAAs to the older population (Ͼ75 years of age). These changes in the epidemiology of AAA disease underlined the need to reevaluate different screening strategies that take into account these emerging contemporary epidemiological data. Such strategies may include screening the entire population at a higher age or limiting screening to older men who smoke. AAA screening is more than just the identification of asymptomatic AAAs; proponents will argue that it also provides valuable opportunities for research on small AAAs. Although it is too early to revise AAA screening at this stage, there is no doubt that screening programs will now need to work harder to prove their worth to the health economists if these trends were to continue.
